GSK To Generics: Hands Off Paxil Patents

Law360, New York (June 27, 2007, 12:00 AM EDT) -- GlaxoSmithKline escalated its war over blockbuster antidepressant Paxil on another front Monday, filing suit against Mylan Laboratories Inc. in a New Jersey district court over the generics maker's alleged patent infringement.

According to the complaint, in September 2005 Mylan filed an Abbreviated New Drug Application with the Food and Drug Administration that infringed the patent—number 7,229,640—for its controlled release version of paroxetine hydrochloride.

In its complaint, GSK adds that it notified Mylan of its patent listing last Wednesday and that Mylan promptly responded that the patent...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.